U.S. Onychomycosis Market: Advancing Antifungal Therapies and Diagnostic Innovations for Nail Infection Treatment
The U.S. Onychomycosis Market is witnessing notable growth as awareness about nail health and advancements in antifungal treatments continue to rise. Onychomycosis, a fungal infection of the toenails or fingernails, is one of the most common nail disorders affecting millions of Americans each year. It is primarily caused by dermatophytes, non-dermatophyte molds, and yeasts such as Candida albicans.
The condition, though not life-threatening, significantly impacts quality of life, leading to pain, discomfort, and aesthetic concerns that drive patients to seek effective medical intervention.
The growing prevalence of chronic diseases such as diabetes and peripheral vascular disorders, which increase susceptibility to fungal infections, is a major market driver. Additionally, the aging population in the U.S., coupled with a rise in immunocompromised individuals, has elevated the demand for onychomycosis treatments. Increasing healthcare expenditure, greater accessibility to dermatological care, and rising awareness about the condition are further contributing to the market’s expansion.
The U.S.…
